InvestLog
GNLX logo

GNLX

Genelux CorporationNASDAQHealthcare
$2.57+0.39%ClosedMarket Cap: $96.7M

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

1

Sales

6

Buy/Sell Ratio

0.17

Total Bought

$0.00

Total Sold

$6.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Mar 26Smalling Ralphofficer: Head of RegulatorySell345$2.4268,313
Thu Mar 26Zindrick Thomasofficer: President and CEOSell3,582$2.42534,849
Thu Mar 26Yu Yongofficer: SVP, Clinical DevelopmentSell906$2.42144,938
Thu Mar 26Cappello Josephofficer: Chief Technical OfficerSell906$2.42155,154
Thu Mar 26Smalling Ralphofficer: Head of RegulatorySell240$2.5168,073
Tue Mar 03Thomas JohndirectorSell10,000$2.90482,784
Wed Jan 07Litten JasonofficerSell0$0.000
Wed Jan 07Litten Jasonofficer: Chief Medical OfficerSell275,000$4.55275,000
Thu Dec 11Cappello Josephofficer: Chief Technical OfficerSell1,463$3.36157,033
Thu Dec 11Cappello Josephofficer: Chief Technical OfficerSell973$5.37156,060
Thu Dec 11Zindrick Thomasofficer: President and CEOSell4,509$5.37538,431
Thu Dec 11Yu Yongofficer: SVP, Clinical DevelopmentSell973$5.37145,844
Thu Dec 11Yu Yongofficer: SVP, Clinical DevelopmentSell3,219$3.36146,817
Thu Dec 11Zindrick Thomasofficer: President and CEOSell12,673$3.33542,940
Thu Dec 11Cappello Josephofficer: Chief Technical OfficerSell1,270$3.33158,496